Concepedia

Xiaoli Liu

XL

Statistics

Publications

5

Citations

126

H-Index

5

Active since

2015

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Xiaoli Liu is an author at Tianjin Medical University Cancer Institute and Hospital specializing in oncology, molecular oncology, and breast cancer prognosis.

ORCID

Publications per year

2015–2022

5

Publications

5

Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4

Yang Li, Daqing Jiang, Qi Zhang et al. · International Journal of Molecular Medicine · 2016 · 46 citations · Full text

, , +14

Low Expression of Slit2 and Robo1 is Associated with Poor Prognosis and Brain-specific Metastasis of Breast Cancer Patients

Fengxia Qin, Huikun Zhang, Li Ma et al. · Scientific Reports · 2015 · 38 citations · Full text

, , +16

Upregulation of miR‐886 indicates poor prognosis and promotes tumour progression of prostate cancer

Bin Pan, Jie Yu, Xiaoli Liu · Andrologia · 2021 · 15 citations

, , +17

Chlorogenic acid regulates the proliferation and migration of high-grade serous ovarian cancer cells through modulating the miR199a5p/DDR1 axis

Wang Li, Ping Zhou, Xuemei Gao et al. · Acta Biochimica Polonica · 2022 · 14 citations · Full text

, , +17

High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy

Huikun Zhang, Yawen Zhao, Xiaoli Liu et al. · Frontiers in Oncology · 2021 · 13 citations · Full text

, , +17

1–5 of 5